Corcept Therapeutics | CORT - Devedores Comerciais





Devedores Comerciais Alterar Data
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Alaunos Therapeutics USD 2K 0 2025-06
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Ardelyx USD 82.84M 10.99M 2026-03
Aurora Cannabis CAD 44.58M 3.68M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Canopy Growth CAD 36.29M 104.13M 2026-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
J&J USD 22.54B 1.21B 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Novartis USD 9.6B 2.69B 2026-03
Omeros USD 8.08M 440K 2024-06
Pacira USD 132.42M 6.78M 2026-06
Pfizer USD 16.19B 19M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06